BiltRx Compounded Tirzepatide
US telehealth platform dispensing compounded tirzepatide at $129 per month through licensed 503A pharmacies.
Find tirzepatide for sale from licensed telehealth providers. We compare compounded and brand-name pricing, verify pharmacy credentials and explain the prescription...
Ranked on the criteria below. Prices and ratings come from the merchant pages.
US telehealth platform dispensing compounded tirzepatide at $129 per month through licensed 503A pharmacies.
Dose-tiered compounded tirzepatide with glycine and B12 from $199.99 per month, free consultation and free shipping included.
We look for a batch-level certificate of analysis published by the merchant.
Purity percentage and milligrams per vial as stated on the product page.
Clear research-use labeling, lot numbers and storage instructions.
Vials compared on price per milligram, not on sticker price.
Tirzepatide for sale through licensed US telehealth platforms costs between $129 and $399.99 per month for compounded formulations, depending on the dose and the provider. Brand-name versions, Zepbound and Mounjaro, list at $1,499 per month without insurance. Every option requires a prescription from a licensed medical provider. This page compares the two compounded providers we verified, explains the buying process from consultation to delivery, and lays out the clinical data so you know what you are paying for.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that alters appetite signaling, gastric emptying and insulin sensitivity. These are powerful metabolic effects. The FDA approved tirzepatide as Mounjaro for type 2 diabetes in 2022 and as Zepbound for chronic weight management in 2023, both under prescription-only classification. The boxed warning on the label flags a risk of thyroid C-cell tumors observed in rodent studies, along with contraindications for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). That warning alone makes unsupervised use dangerous.
Semaglutide (Ozempic, Wegovy) activates only the GLP-1 receptor. Tirzepatide activates both GLP-1 and GIP receptors. The dual mechanism produced greater weight reduction in a head-to-head trial: adults without diabetes lost an average of 20.2% of body weight on tirzepatide versus 13.7% on semaglutide over 72 weeks in SURMOUNT-5 (NEJM, 2025). GIP receptor activation appears to amplify the appetite suppression and metabolic improvements that GLP-1 provides on its own.
Zepbound and Mounjaro are manufactured by Eli Lilly, FDA-approved, and dispensed in pre-filled auto-injector pens at fixed doses. Compounded tirzepatide is prepared by state-licensed 503A pharmacies using the same active ingredient but in multi-dose vials at concentrations set by the prescribing provider. Compounded tirzepatide is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or manufacturing quality the way it reviews branded products. Both compounded providers on this site use US-licensed 503A pharmacies, but buyers should understand this regulatory distinction before ordering.
We verified two telehealth platforms that prescribe compounded tirzepatide through licensed providers and fill prescriptions at US 503A compounding pharmacies. Both are LegitScript certified. The process follows the same four steps at either platform.
Start by checking two things: LegitScript certification and a US pharmacy license. Both verify that the platform operates within federal and state telehealth regulations. We confirmed both for BiltRx and Arc-1. If a provider does not require a prescription or advertises tirzepatide as a "research peptide," that is a disqualifying red flag. Our safety guide lists every warning sign in detail.
The consultation collects your weight, height, medical history and current medications. A licensed provider evaluates whether tirzepatide is appropriate based on your BMI (typically 30 or above, or 27 with a weight-related condition) and screens for contraindications including MTC family history, pancreatitis history and pregnancy. The provider sets the starting dose. Patients do not choose their own dose.
Once prescribed, the compounding pharmacy prepares the medication. BiltRx uses US 503A pharmacies; Arc-1 does the same. The difference is formulation: Arc-1 adds glycine (5 mg/mL) and vitamin B12 (500 mcg/mL) to the tirzepatide. Vials are shipped in insulated packaging to maintain temperature during transit.
Arc-1 includes free expedited shipping. BiltRx charges shipping separately (the exact amount is not published on their site). After delivery, your provider adjusts the dose on a schedule they determine. Neither platform publishes specific dose-escalation timelines publicly; those are individualized during treatment.
The cost gap between compounded and brand-name tirzepatide is significant. Brand-name Zepbound and Mounjaro each list at $1,499 per month before insurance. Compounded options from the two providers we verified range from $129 to $399.99 per month depending on the dose. The table and chart below show the comparison.
| Provider | Monthly Cost | Consultation | Shipping | Notes |
|---|---|---|---|---|
| BiltRx (compounded) | $129 | Extra | Extra | Flat rate, all doses |
| Arc-1 2.5 mg (compounded) | $199.99 | Free | Free | + Glycine + B12 |
| Arc-1 5 mg (compounded) | $249.99 | Free | Free | + Glycine + B12 |
| Arc-1 7.5 mg (compounded) | $399.99 | Free | Free | + Glycine + B12 |
| Zepbound (brand) | $1,499 | Varies | Pharmacy pickup | FDA-approved |
| Mounjaro (brand) | $1,499 | Varies | Pharmacy pickup | FDA-approved |
BiltRx advertises a flat $129 regardless of dose, but consultation and shipping add to the total. Arc-1 includes both in the listed price. At the lowest dose tier, BiltRx is cheaper even with estimated extras. At higher doses, the gap narrows because BiltRx's price stays flat while Arc-1's increases. Our cost calculator lets you compare annual totals with all fees included.
Three verification steps separate a legitimate tirzepatide provider from an unsafe one. We checked all three for both providers listed on this site.
LegitScript is an independent certification body that verifies telehealth platforms and pharmacies against regulatory standards. Both BiltRx and Arc-1 hold current LegitScript certification. You can verify any provider's status directly on the LegitScript website.
Every compounding pharmacy must be licensed in the state where the patient resides. BiltRx states that availability varies by state but does not publish a restriction list. Arc-1 lists five states where it cannot ship: California, Arkansas, Indiana, Minnesota and South Carolina. Before ordering, confirm your state is covered.
Any provider selling tirzepatide without requiring a prescription is operating outside the law. Tirzepatide is a prescription-only medication, both in its FDA-approved and compounded forms. If a website lets you add tirzepatide to a cart without a medical evaluation, do not buy from it.
The SURMOUNT-1 trial (NEJM, 2022) tested tirzepatide in 2,539 adults with obesity but without diabetes over 72 weeks. Weight loss was dose-dependent. These results apply to FDA-approved tirzepatide, not compounded formulations, which have not been studied in controlled trials.
The most common adverse events were gastrointestinal: nausea, diarrhea and constipation, mostly mild to moderate and concentrated during dose escalation. Our weight loss data page breaks down both SURMOUNT-1 and SURMOUNT-5 results in full.
Zepbound and Mounjaro pricing in 2026. Retail cost, insurance coverage options, manufacturer savings programs and how compounded tirzepatide compares.
Compounded tirzepatide vs Zepbound compared on FDA status, pricing, formulation and access. What the differences mean for patients in 2026.
Tirzepatide weight loss results from SURMOUNT-1 and SURMOUNT-5 clinical trials. Dose-specific data on percentage weight loss with verified PubMed sources.
Every guide and ranking on this site is checked by a named reviewer before it is published.
No. Tirzepatide is a prescription medication in all forms, both FDA-approved (Zepbound, Mounjaro) and compounded. Any seller offering it without a medical consultation and prescription is operating illegally. Avoid those sources entirely.
Brand-name tirzepatide (Zepbound, Mounjaro) is manufactured by Eli Lilly, FDA-approved, and dispensed in pre-filled pens. Compounded tirzepatide is prepared by licensed 503A pharmacies from the same active ingredient but is not FDA-approved. The FDA does not review compounded products for safety or effectiveness. Compounded versions cost significantly less but carry different regulatory oversight.
Brand-name Zepbound and Mounjaro list at $1,499 per month before insurance. Compounded tirzepatide from BiltRx costs $129 per month (consultation and shipping extra). Arc-1 charges $199.99 to $399.99 per month depending on dose, with consultation and shipping included. See our cost and insurance guide for full details.
BiltRx states availability varies by state but does not publish a restriction list. Arc-1 does not ship to California, Arkansas, Indiana, Minnesota or South Carolina. Check with each provider before starting the consultation process to confirm your state is covered.
The FDA label for Zepbound and Mounjaro includes a boxed warning about thyroid C-cell tumors (observed in rats) and contraindicates use in patients with MTC or MEN2 history. Other warnings include pancreatitis, gallbladder problems, hypoglycemia (especially with insulin), kidney injury from dehydration, and reduced effectiveness of oral hormonal birth control. Common side effects are nausea, diarrhea, constipation and reduced appetite, usually during dose escalation. Your prescribing provider will screen for all contraindications during the consultation.
